Status:

WITHDRAWN

Rescue Quadratus Lumborum Blocks for Post-cesarean Pain

Lead Sponsor:

The University of Texas Health Science Center, Houston

Conditions:

Morphine

Analgesics

Eligibility:

FEMALE

18-50 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to assess whether quadratus lumborum (QL) block performed 1 day after cesarean delivery will provide supplemental post-cesarean analgesia and reduce opioid requirements.

Eligibility Criteria

Inclusion

  • elective or non-elective cesarean delivery on prior day
  • pain scores \>5/10

Exclusion

  • BMI \>40
  • obstructive sleep apnea
  • drug abuse
  • chronic pain
  • chronic opioid use
  • abdominal surgeries other than cesarean delivery
  • contraindications to neuraxial or regional anesthesia
  • received general anesthesia or did not receive neuraxial morphine for cesarean delivery

Key Trial Info

Start Date :

January 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04397458

Start Date

January 1 2022

End Date

June 30 2022

Last Update

November 3 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030